TG Therapeutics, Inc. TGTX
57.43
(0.09)
(0.16%)
as of 25 Sep
- Market cap
- $8.8B
- P/E
- 18.9×
Follow TGTX
Growth Flags
show if company had growth for consecutive years
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 213.00 | 177.06 | 9.71 |
P/S ratio |
1,435.74 | 3,573.11 | 2,035.62 | 6,453.26 | 39,471.54 | 375.58 | 562.55 | 10.35 | 13.29 | 6.98 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
(12.82) | (24.85) | (9.18) | (32.27) | (115.32) | (28.91) | (65.63) | (183.11) | (170.59) | 218.82 |
P/B ratio |
6.08 | 8.11 | 12.87 | 25.40 | 11.55 | 10.59 | 26.74 | 15.07 | 19.67 | 6.64 |
Price to Tangible BV |
6.22 | 8.20 | 13.32 | 25.94 | 11.57 | 10.63 | 27.11 | 15.15 | 19.74 | 6.65 |
EV/Sales |
1,141.20 | 3,016.52 | 1,583.09 | 5,731.82 | 35,702.31 | 338.65 | 530.61 | 9.86 | 13.10 | 7.15 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 108.64 | 115.77 | 36.42 |
EV/Operating CF |
(2.82) | (4.89) | (1.87) | (6.56) | (25.30) | (7.66) | (8.39) | (73.31) | (106.35) | (177.91) |
EV/FCF |
(2.80) | (4.89) | (1.87) | (6.55) | (25.26) | (7.65) | (8.39) | (73.28) | (106.21) | (176.39) |
Quick Ratio |
2.66 | 3.03 | 1.78 | 1.66 | 6.91 | 4.84 | 3.04 | 5.00 | 4.85 | 2.91 |
Current Ratio |
3.01 | 3.34 | 2.03 | 1.77 | 6.99 | 5.06 | 3.16 | 5.92 | 6.25 | 4.10 |
Net Debt/EBITDA |
0.57 | 0.71 | 0.39 | 0.65 | 2.10 | 0.72 | 0.41 | (5.54) | (1.79) | 0.86 |
Debt/Assets |
0.13% | 0.13% | 0.08% | 18.88% | 5.19% | 17.85% | 37.57% | 30.38% | 42.31% | 23.10% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.80 | 0.06 | 0.29 | 1.24 | 0.62 | 1.10 | 0.38 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.89 | 0.73 | 0.75 |
Operating CF/Net income |
0.79 | 0.79 | 0.74 | 0.77 | 0.77 | 0.85 | 0.79 | (2.48) | (1.73) | (0.06) |
Capex/Depreciation |
(0.66) | (0.01) | 2.90 | (0.21) | (0.28) | (0.19) | (0.01) | 0.00 | 0.01 | 0.09 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (113.87%) | (230.36%) | (381.16%) | (551.85%) | (100.14%) | (92.03%) | (151.36%) | 11.57% | 12.21% | 102.75% | |
| (93.02%) | (155.72%) | (191.70%) | (140.19%) | (70.85%) | (69.26%) | (78.09%) | 4.84% | 5.15% | 54.50% | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 29.91% | 16.82% | 10.25% |
Return on Tangible Assets |
(228.05%) | (180.58%) | (429.11%) | (266.02%) | (53.25%) | (130.78%) | (193.98%) | 4.79% | 4.92% | 93.75% |
Average Days of Receivables |
201.47 | 259.34 | 228.13 | 0.00 | 0.00 | 75.79 | 0.00 | 79.81 | 143.32 | 181.01 |
Research and Development Expense of Revenue |
45,547.37% | 67,455.92% | 104,862.50% | 101,434.21% | 109,142.11% | 3,327.54% | 4,500.97% | 32.61% | 28.66% | 26.00% |
Selling, General and Administrative Expense of Revenue |
6,505.92% | 10,744.08% | 9,974.34% | 9,886.18% | 70,953.95% | 1,914.93% | 3,428.51% | 52.51% | 46.90% | 37.65% |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
4,940.79% | 10,490.13% | 8,477.63% | 7,457.24% | 52,821.71% | 916.04% | 1,603.66% | 16.23% | 12.93% | 10.49% |
Graham Net Nets |
0.15 | 0.12 | 0.06 | 0.03 | 0.08 | 0.08 | 0.02 | 0.06 | 0.05 | 0.05 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.43 | 2.42 | 17.61 |
Earnings Yield |
(35.73%) | (21.83%) | (55.91%) | (17.84%) | (4.59%) | (13.84%) | (14.21%) | 0.47% | 0.56% | 10.30% |
Free Cash Flow Yield |
(28.38%) | (17.27%) | (41.70%) | (13.55%) | (3.58%) | (11.78%) | (11.25%) | (1.30%) | (0.93%) | (0.58%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.02 | 1.65 | 2.26 | 4.27 |
Operating CF per Share |
(1.26) | (1.51) | (1.71) | (1.50) | (1.86) | (2.24) | (1.30) | (0.22) | (0.28) | (0.17) |
Capex per Share |
(0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
(1.26) | (1.51) | (1.71) | (1.50) | (1.86) | (2.24) | (1.30) | (0.22) | (0.28) | (0.17) |
Cash per Share |
0.92 | 1.36 | 0.91 | 1.59 | 5.25 | 2.38 | 1.19 | 1.53 | 2.14 | 0.98 |
Shareholders Equity per Share |
0.73 | 1.08 | 0.32 | 0.44 | 4.50 | 1.79 | 0.43 | 1.13 | 1.53 | 4.49 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.73 | 1.08 | 0.32 | 0.44 | 4.50 | 1.79 | 0.43 | 1.13 | 1.53 | 4.49 |
Free Cash Flow |
(61.93) | (93.76) | (129.01) | (132.94) | (214.86) | (296.03) | (176.18) | (31.41) | (40.56) | (24.99) |
Working Capital |
33.99 | 65.36 | 40.18 | 64.70 | 524.19 | 265.58 | 115.07 | 264.22 | 475.68 | 477.00 |
Capital Expenditures |
(0.34) | 0.00 | (0.09) | (0.13) | (0.36) | (0.40) | (0.01) | — | (0.04) | (0.21) |
Net Current Asset Value |
31.95 | 62.93 | 19.45 | 24.75 | 505.45 | 188.49 | 33.29 | 148.86 | 211.03 | 215.53 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 111.62 | 102.77 | 35.74 |
Capex to Sales |
2.26 | 0.01 | 0.59 | 0.86 | 2.35 | 0.06 | 0.01 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
(51,482.24%) | (77,944.74%) | (114,132.89%) | (113,730.92%) | (183,803.29%) | (5,204.08%) | (8,036.34%) | 5.42% | 7.11% | 72.56% |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 117.24 | 104.32 | 34.88 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.59 | 0.58 | (0.12) | 2.18 | 2.64 | 3.49 | 6.61 | 5.95 | 0.00 | 0.00 |
Cash ROIC |
(76.61%) | (61.91%) | (138.89%) | (63.43%) | (18.58%) | (47.80%) | (60.23%) | (6.59%) | (5.21%) | (2.39%) |
Accounts Receivable Turnover |
1.13 | 1.58 | 1.50 | 0.00 | 0.00 | 9.01 | 0.00 | 8.90 | 3.65 | 2.83 |
Accounts Payable Turnover |
0.01 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.35 | 0.80 | 1.21 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 | 0.85 |
Average Days of Payables |
88,455.72 | 114,625.06 | 150,881.88 | 38,882.85 | 36,123.29 | 23,699.13 | 57,875.23 | 993.70 | 552.88 | 389.62 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,028.62 | 1,047.58 | 455.14 |
Average Receivables |
0.13 | 0.10 | 0.10 | — | — | 0.74 | — | 26.24 | 90.14 | 217.41 |
Average Payables |
12.31 | 20.57 | 31.13 | 33.21 | 33.53 | 44.15 | 46.66 | 40.25 | 48.38 | 82.90 |
Average Inventory |
— | — | — | — | — | — | — | — | 75.14 | 118.02 |
Average Assets |
84.13 | 76.08 | 90.50 | 123.32 | 394.33 | 502.64 | 286.60 | 261.58 | 453.64 | 820.47 |
Average Common Equity |
68.72 | 51.43 | 45.51 | 31.33 | 278.98 | 378.25 | 147.87 | 109.54 | 191.43 | 435.19 |
Columns are period end dates